You are here

  • Home
  • Archive
  • Volume 10, Issue 9
  • Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC)

Article metrics

Article menu

Download PDFPDF

Position article and guidelines
Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC)

 

Online download statistics by month:

Online download statistics by month: September 2022 to July 2025

AbstractFullPdf
Sep 202240341165
Oct 202234113480941
Nov 202215871600425
Dec 2022652656139
Jan 2023680688158
Feb 2023569572167
Mar 2023411415137
Apr 202328329182
May 202321421660
Jun 202323323582
Jul 202319319469
Aug 202319018968
Sep 202318818990
Oct 202318618654
Nov 202316016043
Dec 202323223276
Jan 202410410746
Feb 202414814866
Mar 2024211214101
Apr 202420220282
May 202420320584
Jun 202418618659
Jul 202417918154
Aug 202414214243
Sep 2024797949
Oct 202410810856
Nov 202413813964
Dec 202423824043
Jan 202513813974
Feb 202510110129
Mar 202513013238
Apr 202518518537
May 202514214238
Jun 202511711716
Jul 2025110
Total12344124823635